BIANCONI, MARISTELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.914
EU - Europa 1.061
AS - Asia 453
SA - Sud America 134
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.633
Nazione #
US - Stati Uniti d'America 1.913
IT - Italia 255
UA - Ucraina 193
SG - Singapore 138
BR - Brasile 123
SE - Svezia 120
IE - Irlanda 105
TR - Turchia 104
RU - Federazione Russa 103
DE - Germania 94
CN - Cina 92
DK - Danimarca 75
FI - Finlandia 63
HK - Hong Kong 59
KR - Corea 41
CI - Costa d'Avorio 37
MA - Marocco 24
GB - Regno Unito 23
FR - Francia 13
IN - India 9
BE - Belgio 8
DZ - Algeria 5
NL - Olanda 5
EU - Europa 4
VE - Venezuela 4
BD - Bangladesh 3
CO - Colombia 3
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 3.633
Città #
Chandler 236
Fairfield 217
Jacksonville 206
Wilmington 136
Ashburn 108
Dublin 105
Centro 96
Seattle 95
Boardman 94
Woodbridge 83
Houston 73
Ann Arbor 69
New York 62
Singapore 61
Cambridge 59
Hong Kong 59
Des Moines 51
Lawrence 43
Princeton 43
San Mateo 43
Turin 43
Abidjan 36
Moscow 27
Helsinki 21
Beijing 20
The Dalles 19
San Diego 17
Pune 9
Brussels 8
Izmir 8
London 7
Belo Horizonte 6
Cagliari 6
Los Angeles 6
Munich 6
Norwalk 6
Shanghai 6
Wuxi 6
Guangzhou 5
Kilburn 5
São Paulo 5
Washington 5
Wuhan 5
Brasília 4
Turku 4
Ancona 3
Curitiba 3
Dallas 3
Duque de Caxias 3
Fayetteville 3
Jiaxing 3
Milan 3
New Bedfont 3
Rio de Janeiro 3
Amantea 2
Amsterdam 2
Bogotá 2
Bom Despacho 2
Campinas 2
Chicago 2
Clifton 2
Como 2
Council Bluffs 2
Dalian 2
Florence 2
Fortaleza 2
Guanhães 2
Guarulhos 2
Istanbul 2
Jinhua 2
Marche 2
Modena 2
Montesilvano 2
Ottaviano 2
Piracicaba 2
Porto 2
Prescot 2
Recife 2
Ribeirão Preto 2
Rome 2
Roseto degli Abruzzi 2
San Francisco 2
Scafati 2
Siena 2
Sorocaba 2
Venice 2
Acton 1
Alcobaça 1
Americana 1
Amparo 1
Ananindeua 1
Anta Gorda 1
Aparecida 1
Arcoverde 1
Aripuanã 1
Armação dos Búzios 1
Ascoli Piceno 1
Bagé 1
Baku 1
Basra 1
Totale 2.334
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 140
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 137
Immunotherapy in genitourinary cancers: Where are we going? 137
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 125
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 116
Il profilo angiogenico nel carcinoma renale metastatico: implicazioni prognostiche e terapeutiche 107
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 106
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 102
Adjuvant treatment after surgical resection 102
Neutrophil‑to‑lymphocyte ratio may be associated with the outcome in patients with prostate cancer 101
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 101
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 96
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 95
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 94
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 94
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 93
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 91
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 90
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 88
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 88
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 87
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 86
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 85
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 83
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 83
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 83
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 83
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 79
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 78
Panitumumab for the treatment of metastatic colorectal cancer: A review 76
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 75
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer. 72
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 72
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 70
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 65
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 64
Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. 62
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 61
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 60
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma 57
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice 57
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma 47
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors. 41
Totale 3.729
Categoria #
all - tutte 19.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.875


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202069 0 0 0 0 0 0 0 0 0 0 12 57
2020/2021769 47 71 82 4 126 74 70 48 54 100 64 29
2021/2022370 35 92 4 5 2 19 21 22 18 53 29 70
2022/2023727 53 98 59 48 47 114 1 38 166 3 83 17
2023/2024364 61 2 29 45 54 93 6 11 1 6 8 48
2024/2025658 112 74 10 12 47 29 120 32 139 62 21 0
Totale 3.729